Cargando…
Managing Post COVID-19 Patient with Breathlessness
BACKGROUND: Chronic respiratory disease may be associated with severity of coronavirus disease 2019 (COVID-19) infection. We review a case of chronic obstructive pulmonary disease (COPD) patient who developed acute breathlessness post COVID-19 infection, also focusing on the diagnostic approach. CAS...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9371804/ https://www.ncbi.nlm.nih.gov/pubmed/35968263 http://dx.doi.org/10.1155/2022/7512400 |
_version_ | 1784767239666270208 |
---|---|
author | Wong, Yen Shen Ibrahim, Muhammad Amin Mohd Zim, Mohd Arif Abdul Rani, Mohd Fauzi |
author_facet | Wong, Yen Shen Ibrahim, Muhammad Amin Mohd Zim, Mohd Arif Abdul Rani, Mohd Fauzi |
author_sort | Wong, Yen Shen |
collection | PubMed |
description | BACKGROUND: Chronic respiratory disease may be associated with severity of coronavirus disease 2019 (COVID-19) infection. We review a case of chronic obstructive pulmonary disease (COPD) patient who developed acute breathlessness post COVID-19 infection, also focusing on the diagnostic approach. CASE: A 69-year-old gentleman with background history of COPD GOLD D and ischemic heart disease was admitted with severe COVID-19 infection. He required high-flow nasal cannula upon presentation. A computed tomography pulmonary angiography (CTPA) thorax at day 10 of illness revealed moderate organizing pneumonia (OP) with emphysematous changes, without pulmonary embolism. He received oral baricitinib and intravenous methylprednisolone for 3 days, which was then followed by tapering prednisolone starting dose of 1 mg/kg/day (60 mg/day) with reduction of 10 mg prednisolone every 3 days. COPD pharmacotherapy was optimized with early utilization of dual bronchodilators and inhaled corticosteroid was withheld. He underwent inpatient pulmonary rehabilitation and was discharged with home oxygen therapy. Unfortunately, he was re-admitted after 2 weeks with shortness of breath and fever for 3 days. Blood results revealed leucocytosis with raised C-reactive protein. A repeat CTPA showed increase reticulations and crazy paving pattern with reduction in lung volume. Multidisciplinary team discussion concluded it as interstitial pneumonia with COVID-19 OP and fibrosis progression. Prednisolone was stopped and he responded well with antibiotics. A follow-up at 3 months post COVID-19 infection showed improvement of clinical symptoms with radiological resolution of ground glass changes. CONCLUSION: Corticosteroid inhaler should be cautioned in this case, in view of recent pneumonia and non-elevated serum eosinophil count. These groups of patients should be closely followed up to unmask interstitial lung disease that may present prior to COVID-19 and worsen post-infection. Optimizing pre-existing medical conditions should be the paramount intervention. |
format | Online Article Text |
id | pubmed-9371804 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Hindawi |
record_format | MEDLINE/PubMed |
spelling | pubmed-93718042022-08-12 Managing Post COVID-19 Patient with Breathlessness Wong, Yen Shen Ibrahim, Muhammad Amin Mohd Zim, Mohd Arif Abdul Rani, Mohd Fauzi Case Rep Med Case Report BACKGROUND: Chronic respiratory disease may be associated with severity of coronavirus disease 2019 (COVID-19) infection. We review a case of chronic obstructive pulmonary disease (COPD) patient who developed acute breathlessness post COVID-19 infection, also focusing on the diagnostic approach. CASE: A 69-year-old gentleman with background history of COPD GOLD D and ischemic heart disease was admitted with severe COVID-19 infection. He required high-flow nasal cannula upon presentation. A computed tomography pulmonary angiography (CTPA) thorax at day 10 of illness revealed moderate organizing pneumonia (OP) with emphysematous changes, without pulmonary embolism. He received oral baricitinib and intravenous methylprednisolone for 3 days, which was then followed by tapering prednisolone starting dose of 1 mg/kg/day (60 mg/day) with reduction of 10 mg prednisolone every 3 days. COPD pharmacotherapy was optimized with early utilization of dual bronchodilators and inhaled corticosteroid was withheld. He underwent inpatient pulmonary rehabilitation and was discharged with home oxygen therapy. Unfortunately, he was re-admitted after 2 weeks with shortness of breath and fever for 3 days. Blood results revealed leucocytosis with raised C-reactive protein. A repeat CTPA showed increase reticulations and crazy paving pattern with reduction in lung volume. Multidisciplinary team discussion concluded it as interstitial pneumonia with COVID-19 OP and fibrosis progression. Prednisolone was stopped and he responded well with antibiotics. A follow-up at 3 months post COVID-19 infection showed improvement of clinical symptoms with radiological resolution of ground glass changes. CONCLUSION: Corticosteroid inhaler should be cautioned in this case, in view of recent pneumonia and non-elevated serum eosinophil count. These groups of patients should be closely followed up to unmask interstitial lung disease that may present prior to COVID-19 and worsen post-infection. Optimizing pre-existing medical conditions should be the paramount intervention. Hindawi 2022-08-04 /pmc/articles/PMC9371804/ /pubmed/35968263 http://dx.doi.org/10.1155/2022/7512400 Text en Copyright © 2022 Yen Shen Wong et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Case Report Wong, Yen Shen Ibrahim, Muhammad Amin Mohd Zim, Mohd Arif Abdul Rani, Mohd Fauzi Managing Post COVID-19 Patient with Breathlessness |
title | Managing Post COVID-19 Patient with Breathlessness |
title_full | Managing Post COVID-19 Patient with Breathlessness |
title_fullStr | Managing Post COVID-19 Patient with Breathlessness |
title_full_unstemmed | Managing Post COVID-19 Patient with Breathlessness |
title_short | Managing Post COVID-19 Patient with Breathlessness |
title_sort | managing post covid-19 patient with breathlessness |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9371804/ https://www.ncbi.nlm.nih.gov/pubmed/35968263 http://dx.doi.org/10.1155/2022/7512400 |
work_keys_str_mv | AT wongyenshen managingpostcovid19patientwithbreathlessness AT ibrahimmuhammadamin managingpostcovid19patientwithbreathlessness AT mohdzimmohdarif managingpostcovid19patientwithbreathlessness AT abdulranimohdfauzi managingpostcovid19patientwithbreathlessness |